Regeneron
is a New York-based biotechnology company that researches, develops, and commercializes novel therapeutics for the treatment of inflammatory and infectious diseases... Read moreRegeneron
is a New York-based biotechnology company that researches, develops, and commercializes novel therapeutics for the treatment of inflammatory and infectious diseases... Read more
News
Partnership
Jan 13, 2025
Marketscreener
Regeneron Collaborates with Truveta and Leading American Health Systems to Massively Extend its DNA Sequence-Linked Healthcare Database to Further Advance Scientific Innovation and Healthcare Delivery
investment
Jan 12, 2025
https://www.finanznachrichten.de/nachrichten-2025-01/64274395-regeneron-to-invest-dollar-119-5-mln-in-truveta-s-financing-round-launch-truveta-genome-project-020.htm
Regeneron Pharmaceuticals, Inc. has invested $320M in Truveta, Inc.
Acquisition
Jan 04, 2025
Eyewire News
Regeneron acquired Oxular Limited for undisclosed amount
Conference Presentation
Dec 17, 2024
Benzinga
Regeneron Announces Presentation at the 43rd Annual J.P. Morgan Healthcare Conference
ESG
Dec 16, 2024
Marketscreener
Regeneron Named to Dow Jones Sustainability World Index for Sixth Consecutive Year
Regulatory
Nov 18, 2024
Zacks
FDA Accepts SNY and REGN's Dupixent Re-Submitted sBLA for Urticaria
Regeneron Competitors
1
2
3
4
5
6
7
8
9
10